Rifamycin SV-MMX
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Rifamycin SV-MMX, covering 2019-02-27 to 2023-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years [Phase 2]